Truist reiterates Buy on Amer Sports stock, cites growth runway

Truist reiterated its Buy rating on Amer Sports with a $42 price target, implying roughly 57% upside from the $26.73 share price, and sees a path to approximately $3.00 EPS by 2031. Amer Sports lifted its Q3 2026 revenue-growth outlook to 20%-22% from 18%-20%, while its long-term plan assumes low-double-digit to mid-teens annual revenue growth through 2031. Multiple firms remain constructive, including UBS at a $62 target, BTIG at $42 and BMO at $38, citing brand strength and growth at Arc'teryx, Salomon and Wilson.

Analysis

AS is now a clean execution-versus-expectations setup rather than a fresh fundamental discovery. The key issue is whether Arc’teryx and Salomon can sustain premium sell-through while wholesale footwear and discretionary outdoor demand remain uneven; a higher starting revenue base makes the long-dated earnings framework more credible, but also raises the bar for inventory discipline and full-price mix. The relevant near-term valuation anchor is not the most bullish sell-side target but whether quarterly revenue growth and EBIT margin can continue to exceed a consensus already expecting double-digit expansion.

Competitive read-through is mixed. Salomon’s performance positioning can take share from broad lifestyle-footwear exposure at NKE, DECK and ONON, while Arc’teryx’s scarcity and premium technical positioning are less exposed to promotional pressure than mass outdoor peers such as COLM and VFC. Conversely, if AS pushes channel expansion too quickly, elevated wholesale receivables, rising markdowns, or decelerating direct-to-consumer growth would signal that brand exclusivity is being monetized at the expense of future pricing power.

The immediate catalyst is the next revenue/margin print and any evidence that upgraded growth is translating into gross-margin durability, not merely inventory availability or FX. Over 1-3 months, the stock can rerate if management raises full-year operating-profit expectations and reports clean inventory growth below sales; over 6-18 months, the larger risk is that the market compresses the premium multiple if growth settles into the low teens without incremental margin leverage. Consensus bullishness is meaningful, so upside requires earnings revisions rather than additional rating reiterations.

Contrarian view: the low share price alone does not establish asymmetry. The more constructive interpretation is that AS is a category-share compounder; the bearish interpretation is that investors are discounting a normalization in premium consumer demand and a multi-brand integration/expansion risk. The thesis is falsified by two consecutive quarters of sub-guidance growth, gross-margin contraction, or inventory growth materially above revenue.

Key Decisions for Investors

• Initiate a starter long AS only after the next earnings release confirms revenue at or above updated guidance and stable-to-higher gross margin; target a 15-25% rerating over 3-6 months, with a stop/reassessment on a guidance cut or inventory growth exceeding sales by more than 10 points.
• Express relative strength through long AS / short VFC in equal dollar exposure over 3-6 months: AS has higher premium-brand and performance-category exposure, while VFC remains more vulnerable to promotional intensity and turnaround execution. Exit if AS comparable/direct growth decelerates sharply or VFC demonstrates sustained margin recovery.
• Use DECK and ONON as read-through alerts rather than direct hedges: weak premium footwear sell-through, wholesale order commentary, or elevated promotions from either would increase downside risk to Salomon assumptions before AS reports.
• Do not underwrite the long-term EPS framework into position sizing until management provides evidence of operating leverage: require quarterly EBIT-margin expansion and inventory/receivables discipline. Without those datapoints, treat bullish price targets as sentiment support, not a catalyst.